Plain-English translation of NCT07139301 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After an emergency procedure to remove a blood clot from the brain during a stroke, patients with atrial fibrillation (an irregular heart rhythm) need to take blood thinners to prevent future strokes. This trial is testing whether starting direct oral anticoagulants (DOACs) early — within 4 days — or waiting longer — between 5 and 14 days — is safer and more effective for these patients.
Doctors want to prevent another stroke, but they also worry about bleeding risks after the emergency procedure. By testing different timing strategies, researchers hope to find the safest moment to start this medication without increasing the chance of brain bleeding.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either an early treatment group (starting the blood thinner within 4 days of your stroke) or a delayed treatment group (starting it between days 5 and 14). Your doctors will monitor you closely during your hospital stay and schedule follow-up visits for 90 days after your stroke to check how well the medication is working and watch for any bleeding or other problems.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
China